Medivir - Science working wonders medivir.se This Swedish version of medivir.com contains only translations of selected parts of the content from the English page. For complete information and access to complete content, please refer to the medivir.com page. ENGLISH SITE - MEDIVIR.COM FROM DISCOVERY TO REMEDY Medivir is a pharmaceutical company focusing on the development of transformative cancer drugs. Our current projects MIV-818 Nucleotide DNA polymerase inhibitor (oral) MORE ABOUT MIV-818 Birinapant SMAC mimetic (intravenous) MORE ABOUT BIRINAPANT VIEW ALL OUR CURRENT PROJECTS Pressmeddelanden 2021-12-01 Medivir presenterar vid Erik Penser Banks Temadag - Life Science LÄS MER 2021-11-18 Resultat publicerade från prövarinitierad klinisk fas II-studie av remetinostat hos patienter med skivepitelcancer LÄS MER 2021-11-11 Medivir presenterar vid Redeye Life Science Day LÄS MER LÄS NYHETER & PRESS RELEASER Partner with Medivir Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale. READ MORE Post Medivir AB Box 1086 SE-141 22 Huddinge Visiting address: Lunastigen 5, 2 tr Phone +46 (0) 8 546 831 00 Email info@medivir.com Our privacy policy Read more Magnus Christensen Interim Chief Executive Officer and Chief Financial Officer magnus.christensen@medivir.com At medivir.se we use cookies to adapt information and content in the best way for you. By continuing to use our website, you agree to the use of cookies. Read more in our privacy policy . I accept cookies

Bolagsstämmor 2020-12-11 2021 2020-03-24 2020 2019-05-09 2019 2018-01-10 2018 2017-05-03 2017 2016-05-03 2016 2015-05-05 2015 2014-05-08 2014 2013-05-06 2013 2012-05-10 2012 2011-05-05 2011 2010-04-29 2010 2009-04-23 2009 2008-04-23 2008 Post Medivir AB Box 1086 SE-141 22 Huddinge Visiting address: Lunastigen 5, 2 tr Phone +46 (0) 8 546 831 00 Email info@medivir.com Our privacy policy Read more Magnus Christensen Interim Chief Executive Officer and Chief Financial Officer magnus.christensen@medivir.com At medivir.se we use cookies to adapt information and content in the best way for you. By continuing to use our website, you agree to the use of cookies. Read more in our privacy policy . I accept cookies